Steven Cohen’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,389,403
Closed -$3.42M 4277
2026
Q1
$3.42M Sell
1,389,403
-909,098
-40% -$3.04M ﹤0.01% 1951
2025
Q4
$9.15M Buy
2,298,501
+2,221,153
+2,872% +$9.83M 0.01% 1417
2025
Q3
$292K Buy
+77,348
New +$263K ﹤0.01% 2075
2022
Q1
Sell
-16,900
Closed -$801K 1271
2021
Q4
$801K Buy
+16,900
New +$1.01M ﹤0.01% 938

Other funds holding NBP

Steven Cohen's NBP Position: Q2 2026 in Review

Steven Cohen sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026, closing a stake of 1,389,403 shares — an estimated $3.42M sold.

Steven Cohen first reported a position in NBP in Q4 2021 and held it in 4 quarters. The position peaked at $9.15M in Q4 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Steven Cohen reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 1,389,403 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $3.42M.
  • Steven Cohen first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2021 and held it in 4 quarters.
  • Steven Cohen's NovaBridge Biosciences American Depositary Shares position peaked at $9.15M in Q4 2025.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.